Market Currents
Regeneron Pharmaceuticals (REGN -0.7%) announces that the FDA has approved Eylea Injection for...
-
Friday, September 21, 2012, 2:59 PM ETRegeneron Pharmaceuticals (REGN -0.7%) announces that the FDA has approved Eylea Injection for the treatment of macular edema. The approval was based on data from Phase 3 studies which showed results for Eylea were superior to those for the sham control group for the primary endpoint.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
